InvestSMART

LTR Pharma Ltd (ASX: LTP) - Announcements

Current share price for LTP : $0.430 0.02 (4.88%)+

ASX company news and announcements for LTR Pharma Ltd (LTP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All LTR Pharma Ltd (LTP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than LTR Pharma Ltd (LTP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for LTR Pharma Ltd (LTP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$78 Suspension from Quotation 6 Jun 2024 10:42AM $0.640 $0.430 fallen by 32.81%
$78 Trading Halt 4 Jun 2024 9:11AM $0.640 $0.430 fallen by 32.81%
$78 Response to ASX Price Query 22 May 2024 3:44PM $0.495 $0.430 fallen by 13.13%
$78 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2024 9:38AM $0.255 $0.430 risen by 68.63%
$78 Notification regarding unquoted securities - LTP 18 Apr 2024 4:59PM $0.280 $0.430 risen by 53.57%
$78 Final Patients dosed in SPONTAN pivotal study 25 Mar 2024 9:05AM $0.305 $0.430 risen by 40.98%
$78 First patients dosed in SPONTAN pivotal study 19 Mar 2024 8:45AM $0.305 $0.430 risen by 40.98%
$78 Investor Presentation 18 Mar 2024 8:32AM $0.320 $0.430 risen by 34.38%
$78 Appendix 4D and Half Yearly Report 28 Feb 2024 8:10AM $0.290 $0.430 risen by 48.28%
$78 Recruitment commences for SPONTAN Clinical Study 19 Feb 2024 8:11AM $0.300 $0.430 risen by 43.33%
$78 Notification regarding unquoted securities - LTP 16 Feb 2024 9:15AM $0.305 $0.430 risen by 40.98%
$78 SPONTAN Achieves Key Manufacturing Validation 6 Feb 2024 8:23AM $0.330 $0.430 risen by 30.30%
$78 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2024 8:16AM $0.310 $0.430 risen by 38.71%
$78 Response to ASX Query Letter 19 Dec 2023 5:53PM $0.320 $0.430 risen by 34.38%
$78 Positive Clinical Data presented at the WMSM in Dubai 18 Dec 2023 9:26AM $0.330 $0.430 risen by 30.30%
$78 Initial Director's Interest Notice - M McGuire 13 Dec 2023 10:35AM $0.290 $0.430 risen by 48.28%
$78 Initial Director's Interest Notice - J Chick 13 Dec 2023 10:32AM $0.290 $0.430 risen by 48.28%
$78 Initial Director's Interest Notice - L Rodne 13 Dec 2023 10:31AM $0.290 $0.430 risen by 48.28%
$78 Investor Presentation 11 Dec 2023 10:30AM n/a $0.430 n/a
$78 Investor Webinar 8 Dec 2023 12:02PM n/a $0.430 n/a
$78 LTR Pharma to List on the ASX 8 Dec 2023 9:53AM n/a $0.430 n/a
$78 Replacement Prospectus 7 Dec 2023 2:59PM n/a $0.430 n/a
$78 Corporate Governance Plan 7 Dec 2023 1:07PM n/a $0.430 n/a
$78 Pre-Quotation Disclosure 7 Dec 2023 1:06PM n/a $0.430 n/a
$78 Top 20 Holders Group Report 7 Dec 2023 1:05PM n/a $0.430 n/a

126 - 150 of 158 results

Page 6 of 7

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.